Excision repair cross-complementing gene 1 (ERCC1) protein expression in colorectal cancer

被引：0
作者：
Richman, SD [1 ]
Adlard, JW [1 ]
Seymour, MT [1 ]
Quirke, P [1 ]
机构：
[1] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England
来源：
BRITISH JOURNAL OF CANCER | 2002年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
[21]   Excision repair cross complementing group 1 (ERCC1) predicts the efficacy of chemoradiotherapy for invasive bladder cancer [J].
Kawashima, Atsunari ;
Nakayama, Masashi ;
Kakuta, Yoichi ;
Abe, Toyofumi ;
Sato, Mototaka ;
Hatano, Koji ;
Mukai, Masatoshi ;
Nagahara, Akira ;
Oka, Daizo ;
Nakai, Yasutomo ;
Takayama, Hitoshi ;
Yoshioka, Toshiaki ;
Hoshida, Yoshihiko ;
Itatani, Hiroaki ;
Nishimura, Kazuo ;
Nonomura, Norio .
CANCER RESEARCH, 2011, 71
[22]   The Contribution of Excision Repair Cross-complementing Group 1 Genotypes to Colorectal Cancer Susceptibility in Taiwan [J].
Yueh, Te-Cheng ;
Chou, An-Kuo ;
Gong, Chi-Li ;
Fu, Chun-Kai ;
Pei, Jen-Sheng ;
Wu, Ming-Hsien ;
Tsai, Chia-Wen ;
Chang, Wen-Shin ;
Hsiao, Chieh-Lun ;
Yen, Shiou-Ting ;
Li, Hsin-Ting ;
Bau, Da-Tian .
ANTICANCER RESEARCH, 2017, 37 (05) :2307-2313
[23]   Changes in expression levels of excision repair cross-complementing group 1 (ERCC1) and dihydropyrimidine dehydrogenase (DPD) during firstline oxaliplatin-based treatment of advanced metastatic colorectal cancer (mCRC). [J].
Baba, Hideo ;
Watanabe, Masayuki ;
Okabe, Hirohisa ;
Miyamoto, Yuji ;
Sakamoto, Yasuo ;
Baba, Yoshifumi ;
Iwatsuki, Masaaki ;
Chikamoto, Akira ;
Beppu, Toru .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
[24]   miR-138-5p modulates the expression of excision repair cross-complementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin [J].
Ning, Jie ;
Jiao, Yang ;
Xie, Xiaoque ;
Deng, Xuefei ;
Zhang, Yiyin ;
Yang, Yuexin ;
Zhao, Chenchen ;
Wang, Hua ;
Gu, Kangsheng .
ONCOLOGY REPORTS, 2019, 41 (02) :1131-1139
[25]   Clinical significance of dihydropyrimidine dehydrogenase (DPD), epidermal growth factor receptor (EGFR), and excision repair cross-complementing gene 1 (ERCC1) gene expression of tumor tissue in patients with advanced gastric cancer [J].
Nishina, T. ;
Matsubara, J. ;
Toshikazu, M. ;
Yamada, Y. ;
Kajiwara, T. ;
Shimoda, T. ;
Okayama, Y. ;
Sugimoto, Y. ;
Oka, T. ;
Shirao, K. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[26]   RETRACTED: Chemoresistance in gastric cancer is attributed to the overexpression of excision repair cross-complementing 1 (ERCC1) caused by microRNA-122 dysregulation (Retracted Article) [J].
Song, Ai-Ling ;
Zhao, Lei ;
Wang, Yan-Wei ;
He, Dong-Qiang ;
Li, Yu-Min .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (12) :22485-22492
[27]   The prognostic value of excision repair cross-complementing Group 1 expression in nasopharyngeal cancer patients [J].
Chitapanarux, Imjai ;
Lekawanvijit, Suree ;
Sripan, Patumrat ;
Mahanupab, Pongsak ;
Chakrabandhu, Somvilai ;
Onchan, Wimrak ;
Sittitrai, Pichit ;
Boonlert, Donyarat ;
Klibngern, Hanpon ;
Samuckkeethum, Wisarut .
JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2020, 25
[28]   The role of thymidylate synthase (TS) and excision repair cross-complementing group 1 (ERCC1) immunohistochemical expression in malignant pleural mesothelioma patients treated with pemetrexed and carboplatin [J].
Zucali, P. ;
Destro, A. ;
Ceresoli, G. L. ;
Gianoncelli, L. ;
Lorenzi, E. ;
De Vincenzo, F. ;
Simonelli, M. ;
Giordano, L. ;
Roncalli, M. ;
Santoro, A. .
EJC SUPPLEMENTS, 2009, 7 (02) :543-543
[29]   EXPRESSION AND PROGNOSTIC ROLE OF EXCISION REPAIR CROSS COMPLEMENTING GROUP 1 (ERCC1) IN EARLY STAGE BREAST CANCER (BC) PATIENTS (PTS) [J].
Minenza, Elisa ;
Colozza, Mariantonietta ;
Sidoni, Angelo ;
Gori, Stefania ;
Sormani, Maria Pia ;
Cartaginese, Fabio ;
Fenocchio, Daniela ;
Azienda, Lucio Crino L. .
ANNALS OF ONCOLOGY, 2009, 20
[30]   Analysis of excision repair cross complementing group 1 (ERCC1) expression in squamous cell carcinoma of the head and neck (SCCHN) [J].
Mehra, Ranee ;
Cai, Qi K. ;
Zhu, Fang ;
Godwin, Andrew ;
Burtness, Barbara .
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
12345